Status:

RECRUITING

A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules

Lead Sponsor:

Vanderbilt-Ingram Cancer Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Pulmonary Nodule

Eligibility:

All Genders

21+ years

Brief Summary

This is a prospective, multicenter observational study aim at estimating the potential clinical utility of the CBM and at establishing the SOPs and protocols for a future randomized control trial.

Detailed Description

Objectives: * To obtain the combined biomarker model (hs-CYFRA 21-1, radiomics, Mayo) score in a prospective observational trial and estimate potential clinical utility compared to the Mayo Model. * ...

Eligibility Criteria

Inclusion

  • Adults \> 21 y/o
  • IPNs 8-30mm referred for evaluation Figure 4. AUC and reclassification of Combined Biomarker Model
  • Intermediate risk IPN defined as 10-70% risk after applying Mayo risk predictor model
  • Solid nodules or part-solid nodules with solid component \>=8mm
  • CT scan with nodule of concern performed within 60 days of enrollment

Exclusion

  • Pure ground glass nodule or subsolid nodule with solid component \<8mm
  • Currently on therapy for any cancer
  • History of primary lung cancer within the last 5 years
  • Multiple nodules highly suspicious for metastatic disease
  • Other malignancy within the last 2 year - Excluding skin cancer other than melanoma
  • Pregnant women
  • Prisoners
  • Inability to provide informed consent
  • Serologic evidence of active fungal infection

Key Trial Info

Start Date :

March 7 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 31 2029

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06074133

Start Date

March 7 2024

End Date

March 31 2029

Last Update

August 20 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Rocky Mountain Regional VA Medical Center

Aurora, Colorado, United States, 80045

2

University of Colorado

Aurora, Colorado, United States, 80045

3

Vanderbilt University/Ingram Cancer Center

Nashville, Tennessee, United States, 37203

4

VA Tennessee Valley Healthcare Center

Nashville, Tennessee, United States, 37212

A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules | DecenTrialz